AXOSIM
AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform that looks and acts like a real nerve. The company empowers advancements in human neuroscience and accelerates the drug development process through its drug discovery platforms, NerveSim and BrainSim. AxoSim was founded in 2014 and is based in New Orleans, Louisiana.
AXOSIM
Industry:
Biopharma Biotechnology Life Science Medical Neuroscience
Founded:
2014-01-01
Address:
New Orleans, Louisiana, United States
Country:
United States
Website Url:
http://www.axosim.com
Total Employee:
11+
Status:
Active
Contact:
(504)609-3474
Email Addresses:
[email protected]
Total Funding:
10.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Google Tag Manager WordPress Google Analytics Content Delivery Network Global Site Tag Sitelinks Search Box Google Analytics 4
Similar Organizations
MapLight Therapeutics
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
humm
humm harnesses cutting-edge neuroscience into products that allow people to learn faster and perform better.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Ontera
Ontera develops a hand-held point of use diagnostic platform that examines DNA and RNA, and analytes from any life form.
REVAI
REVAI is disrupting traditional learning speeds by leveraging cutting-edge technology in neuroscience to enhance human cognition.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
SpyBiotech
SpyBiotech Operators of a biotechnology platform intended to generate next-generation vaccines.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Xiant Technologies
Xiant Technologies is an agricultural-tech company that delivers specific wavelengths and patterns of light to maximize production.
Current Advisors List
Current Employees Featured
Founder
Investors List
New Orleans BioFund
New Orleans BioFund investment in Series A - AxoSim
Jefferson Capital Partners
Jefferson Capital Partners investment in Private Equity Round - AxoSim
Benson Capital Partners
Benson Capital Partners investment in Private Equity Round - AxoSim
New Orleans BioFund
New Orleans BioFund investment in Seed Round - AxoSim
Great Stuff Ventures
Great Stuff Ventures investment in Venture Round - AxoSim
National Institutes of Health
National Institutes of Health investment in Grant - AxoSim
National Institutes of Health
National Institutes of Health investment in Grant - AxoSim
National Institutes of Health
National Institutes of Health investment in Grant - AxoSim
New Orleans BioFund
New Orleans BioFund investment in Seed Round - AxoSim
Laconia Ventures
Laconia Ventures investment in Seed Round - AxoSim
Key Employee Changes
| Date | New article |
|---|---|
| 2024-06-11 | AxoSim Appoints Alif Saleh as Chief Executive Officer to Drive Market Adoption |
Official Site Inspections
http://www.axosim.com Semrush global rank: 7.61 M Semrush visits lastest month: 725
- Host name: aec037177372cc6cd.awsglobalaccelerator.com
- IP address: 3.33.251.168
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "AxoSim"
Team - AxoSim
Megan manages AxoSim operations with an emphasis on commercial activities and the integration of both quality management and HSSE (health, safety, security, and …See details»
AxoSim - LinkedIn
AxoSim's platforms have applications in peripheral neuropathy and neuropathic pain, disease modeling (such as ALS, MS, and CMT), and neurotoxicology. ... Is your organization interested in ...See details»
AxoSim - Crunchbase Company Profile & Funding
AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform that looks and acts like a real nerve. The …See details»
AxoSim 2025 Company Profile: Valuation, Funding & Investors
AxoSim General Information Description. Developer of a brain-on-a-chip platform designed to capture neurological processes in the brain and nervous system. The company's platform …See details»
AxoSim - The Org
AxoSim is a contract research organization that empowers advancements in human neuroscience through our drug discovery platforms. Industries. Biotechnology. Headquarters. New Orleans, …See details»
AxoSim Company Profile | Management and Employees List
AxoSim Profile and History. AxoSim, Inc. is a premier provider of neurological drug discovery platforms. The company's proprietary BrainSim and NerveSim platforms provide accurate, …See details»
AxoSim Company Profile - Office Locations, Competitors, Revenue …
AxoSim is a biotech company specializing in the development of neurological drugs. It offers the Nerve-on-a-Chip platform that facilitates the prediction of both clinical neurotoxicity and …See details»
AxoSim - The Idea Village
AxoSim is the premier provider of Nerve-on-a-Chip and Minibrain platforms. As an alternative to animal testing, we deliver more effective and safer drugs at a fraction of the time and cost. ... A …See details»
AxoSim | Seed
A .gov website belongs to an official government organization in the United States. Secure .gov websites use HTTPS A lock A locked padlock) or https ... AxoSim’s NerveSim® and BrainSim® platforms are revolutionizing the way …See details»
AxoSim Technologies - New Orleans BioInnovation Center
Dec 9, 2014 AxoSim is a contract research organization dedicated to improving preclinical pharmaceutical development. Using advanced “nerve-on-a-chip” technology developed at …See details»
AxoSim, Inc. - New Orleans, USA - bionity.com
AxoSim is a contract research organization that empowers advancements in human neuroscience through our drug discovery platforms: NerveSim®, powered by Nerve-on-a-Chip®, and …See details»
AxoSim - Funding, Financials, Valuation & Investors - Crunchbase
AxoSim is an operator of a biomimetic neuroscience discovery platform used to develop a 3D cell-based platform. ... Pricing. Log In. Log In. Experience the new Crunchbase, powered by AI . …See details»
AxoSim - Overview, News & Similar companies | ZoomInfo.com
AxoSim contact info: Phone number: (504) 407-7419 Website: www.axosim.com What does AxoSim do? AxoSim, Inc. is a premier provider of neurological drug discovery platforms. The …See details»
Axosim Company Information - Funding, Investors, and More
Get information on funding, investors, industries, and more for Axosim. See Axosim company profile and funding data.See details»
Lab-grown Human Nerve Cells Accelerate Development of New …
Jun 28, 2024 transformed to better predict drug toxicity. The name AxoSim comes from joining the words axon—the tail end of a nerve cell—and simulate. Then in 2016, AxoSim, in …See details»
AXOSIM EXTENDS LEADERSHIP IN HUMAN ORGANOIDS FOR …
New Orleans, La. ─ October 24, 2023 ─ AxoSim, Inc., a leader in the development and application of live biomimetic human drug discovery platforms for neurological diseases, today …See details»
AxoSim | COLAAB
AxoSim partners with preclinical scientists to solve advanced problems in the drug discovery and development processes. They provide rodent and human predictive in vitro modeling via …See details»
Predicting Clinical Neurotoxicity Using Functional Organoids
Andrew LaCroix is a Lead Scientist at AxoSim specializing in the development of iPSC-derived brain organoid models and their applications to preclinical safety and efficacy testing. …See details»
Ax-4 to Set Record for Most Research Activities Conducted During …
Axiom Space revealed today new details about the scientific research and technology demonstrations set to fly on Axiom Mission 4 (Ax-4) to the International Space Station no …See details»
Platform - AxoSim
Platfrom Healthy control Injured or induced toxicity Treated with drug and rescued Brain-on-a-chip platform leveraging tissue engineering, neural interfacing and AI to test groundbreaking […]See details»